Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
GlaxoSmithKline Plc raised its hostile takeover offer for Human Genome Sciences Inc. to about $14 a share, Reuters reported, citing two people familiar with the situation.
On Air Now
Max 250 characters
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC